Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes

Aims: To evaluate the protective effects of exogenous pancreatic kallikrein (PKK) treatment on diabetic cardiomyopathy (DCM) and explore the underlying mechanisms. Methods and Results: Streptozotocin (STZ)-induced diabetic rats, a type 1 diabetic model, were treated with either PKK or saline for 12...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Meng, Yang, Yeping, Wang, Meng, Zeng, Fangfang, Li, Qin, Liu, Wenjuan, Guo, Shizhe, He, Min, Wang, Yi, Huang, Jie, Zhou, Linuo, Li, Yiming, Hu, Ji, Gong, Wei, Zhang, Zhaoyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091235/
https://www.ncbi.nlm.nih.gov/pubmed/30131697
http://dx.doi.org/10.3389/fphar.2018.00855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091235/
https://www.ncbi.nlm.nih.gov/pubmed/30131697
http://dx.doi.org/10.3389/fphar.2018.00855

Ejemplares similares